Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10597667 | 0.67 | GAA (0.41) | GAAL3MBTL1KDM4EALDH1A1HSD17B10 | |
| SCHEMBL18545708 | 0.65 | GAA (0.56) | GAAL3MBTL1KDM4EALDH1A1HSD17B10 | |
| SCHEMBL377190 | 0.65 | GAA (0.56) | GAAL3MBTL1KDM4EALDH1A1HSD17B10 | |
| Hydrochloric Acid SCHEMBL7607254 | 0.65 | GAA (0.40) | GAAL3MBTL1KDM4EALDH1A1HSD17B10 | |
| SCHEMBL563891 | 0.63 | GAA (0.35) | GAAL3MBTL1ALDH1A1 | |
| SCHEMBL13060033 | 0.62 | GAA (0.52) | GAAL3MBTL1 | |
| SCHEMBL19186311 | 0.59 | GAA (0.43) | GAAL3MBTL1KDM4EALDH1A1HSD17B10 | |
| SCHEMBL4449961 | 0.59 | GAA (0.60) | GAAL3MBTL1KDM4EALDH1A1HSD17B10 | |
| SCHEMBL3622381 | 0.59 | GAA (0.32) | GAAL3MBTL1 | |
| SCHEMBL143973 | 0.59 | GAA (0.48) | GAAL3MBTL1KDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100310471-A1 | ANTIOXIDANT AND PARAMAGNETIC HEPARIN-NITROXIDE DERIVATIVES | Johannes Gutenberg-Universität Mainz (DE) | 2010-12-09 | — | — | US | claimed |
| WO-2009027056-A2 | ANTIOXIDANT AND PARAMAGNETIC HEPARIN-NITROXIDE DERIVATIVES | JOHANNES GUTENBERG-UNIVERSITÄT MAINZ vertreten durch den Präsidenten (DE) | 2009-03-05 | — | — | WO | claimed |
| EP-2030624-A1 | Antioxidant and paramagnetic heparin-nitroxide derivatives | Johannes Gutenberg Universität (DE) | 2009-03-04 | — | — | EP | claimed |
| US-20100310471-A1 | ANTIOXIDANT AND PARAMAGNETIC HEPARIN-NITROXIDE DERIVATIVES | Johannes Gutenberg-Universität Mainz (DE) | 2010-12-09 | — | — | US | disclosed |
| WO-2009027056-A2 | ANTIOXIDANT AND PARAMAGNETIC HEPARIN-NITROXIDE DERIVATIVES | JOHANNES GUTENBERG-UNIVERSITÄT MAINZ vertreten durch den Präsidenten (DE) | 2009-03-05 | — | — | WO | disclosed |
| EP-2030624-A1 | Antioxidant and paramagnetic heparin-nitroxide derivatives | Johannes Gutenberg Universität (DE) | 2009-03-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100310471-A1 | ANTIOXIDANT AND PARAMAGNETIC HEPARIN-NITROXIDE DERIVATIVES | PRDX3, PRDX5, PRDX1 | GAA 580/4885L3MBTL1 3110/4885KDM4E 1728/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.